Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

8.95
+0.11001.24%
Post-market: 8.90-0.0500-0.56%19:03 EDT
Volume:350.84K
Turnover:3.11M
Market Cap:761.32M
PE:-16.20
High:8.99
Open:8.81
Low:8.70
Close:8.84
Loading ...

Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

Associated Press Finance
·
23 Dec 2024

Anavex Life Sciences' Loss Widens on Higher Costs

Dow Jones
·
23 Dec 2024

Anavex Life Sciences Q4 2024 GAAP EPS $(0.14) Beats $(0.16) Estimate; Cash Of $132.2M

Benzinga
·
23 Dec 2024

Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

THOMSON REUTERS
·
23 Dec 2024

Anavex Life Sciences Corp Qtrly Loss per Share $0.14

THOMSON REUTERS
·
23 Dec 2024

Stock Track | Anavex Life Sciences Soars 9.85% in Pre-Market on EMA Acceptance of Alzheimer's Drug Filing

Stock Track
·
23 Dec 2024

Anavex receives EMA filing acceptance for treatment of Alzheimer’s disease

TIPRANKS
·
23 Dec 2024

Options Volatility and Implied Earnings Moves This Week, December 23 – December 26, 2024

TIPRANKS
·
23 Dec 2024

Blarcamesine Receives Ema Filing Acceptance for Treatment of Alzheimer’s Disease

THOMSON REUTERS
·
23 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
23 Dec 2024

Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday

Benzinga
·
23 Dec 2024

What To Expect in the Markets This Week

Investopedia
·
22 Dec 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
19 Dec 2024

Anavex announces upcoming presentation of data from ATTENTION-AD study

TIPRANKS
·
09 Dec 2024

Anavex Life Sciences Down Over 13%, On Track for Largest Percent Decrease Since January -- Data Talk

Dow Jones
·
06 Dec 2024

Anavex Life Sciences Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Nov 2024

Buy Recommendation for Anavex Life Sciences: Promising Alzheimer’s Treatment and Expanding Clinical Pipeline

TIPRANKS
·
27 Nov 2024

Anavex Submits Marketing Authorization Application to EU Regulator for Blarcamesine to Treat Alzheimer's; Shares Jump Pre-Bell

MT Newswires Live
·
26 Nov 2024

Anavex gains after seeking EU marketing nod for Alzheimer’s drug

seekingalpha
·
26 Nov 2024

Anavex announces submission of blarcamesine MAA to EMA

TIPRANKS
·
26 Nov 2024